News and Updates
- Solanezumab Phase 3 Study Data from Lilly is Now Available on AD Workbench
- Alzheimer's Prevention Initiative (API) Generation Program data are now accessible to researchers on the AD Workbench from the Alzheimer’s Disease Data Initiative (AD Data Initiative).
- A new collaboration to use UK health data in dementia research.
Watch Our Video
For more information, please contact media@alzheimersdata.org.